Cargando…
Burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (cCMV) infection in Germany: A retrospective statutory health insurance claims database analysis
BACKGROUND: Congenital cytomegalovirus (cCMV) infection can have a broad range of manifestations. This study aimed to assess cCMV-associated sequelae and healthcare resource utilization (HCRU) in infants during the first year of life in Germany. METHODS: A retrospective, controlled cohort study usin...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653416/ https://www.ncbi.nlm.nih.gov/pubmed/37972113 http://dx.doi.org/10.1371/journal.pone.0293869 |
_version_ | 1785147772330049536 |
---|---|
author | de Lepper, Marion Stephan, Anna-Janina Wölle, Regine Wang, Wei Jacob, Christian Schneider, Kim Maren Buxmann, Horst Goelz, Rangmar Hamprecht, Klaus Kummer, Peter Modrow, Susanne Greiner, Wolfgang Luzak, Agnes Reuschenbach, Miriam |
author_facet | de Lepper, Marion Stephan, Anna-Janina Wölle, Regine Wang, Wei Jacob, Christian Schneider, Kim Maren Buxmann, Horst Goelz, Rangmar Hamprecht, Klaus Kummer, Peter Modrow, Susanne Greiner, Wolfgang Luzak, Agnes Reuschenbach, Miriam |
author_sort | de Lepper, Marion |
collection | PubMed |
description | BACKGROUND: Congenital cytomegalovirus (cCMV) infection can have a broad range of manifestations. This study aimed to assess cCMV-associated sequelae and healthcare resource utilization (HCRU) in infants during the first year of life in Germany. METHODS: A retrospective, controlled cohort study using German claims data from the Institute for Applied Health Research Berlin (InGef) database was conducted. cCMV-associated sequelae and HCRU during the first year of life were assessed by matching (1:60) infants with at least one inpatient/outpatient cCMV diagnosis (ICD-10-GM: P35.1) ≤90 days after birth (cCMV(90) cohort) and infants with at least one inpatient cCMV diagnosis plus specific sequelae ≤21 days after birth (cCMV(21-S)) to infants without cCMV or CMV (ICD-10-GM: B25) diagnosis (control group), respectively. Outcomes were analyzed during the first 365 days of life. RESULTS: Between 2014–2018, we identified 54 newborns for cCMV(90) and 24 newborns for cCMV(21-S) cohort. Compared to the 3,240 and 1,440 controls, respectively, more cCMV(90) infants (83.3% vs. 41.9%, p<0.01) presented with at least one sequela during the first year of life, including intrauterine growth retardation (42.6% vs. 5.3%, p<0.01), sensorineural hearing loss (SNHL) to deafness (38.9% vs. 2.2%, p<0.01), and motor development disorders (33.3% vs. 10.9%, p<0.01). Further, 13.0% of cCMV(90) infants (vs. 2.3%, p<0.01) suffered from visual impairment. In cCMV(21-S) cohort, intrauterine growth retardation (79.2% vs. 6.0%, p<0.01), prematurity (54.2% vs. 7.3%, p<0.01), and motor development disorders (50.0% vs. 11.0%, p<0.01) were the most frequent sequelae. Infants in the cCMV(90) and cCMV(21-S) cohort had, on average, 7.3 times and 9.5 times more hospitalizations and 2.0 times and 2.1 times more outpatient physician visits than their respective controls (p<0.01). Hospitalized infants with cCMV stayed, on average, significantly longer in hospital compared to their controls (cCMV(90) cohort: 30.3 days vs. 9.0 days, p<0.01; cCMV(21-S) cohort: 46.5 days vs. 9.3 days, p<0.01). CONCLUSIONS: cCMV-infection shows a considerable disease and healthcare burden during the first year of life. More than 80% of the identified newborns with cCMV suffered from at least one associated sequela during the first year of life, including long-term sequelae such as SNHL (40%) and visual impairment (13%). Additional steps for prevention of cCMV infection and associated sequelae as well as a comprehensive monitoring of disease burden are needed. |
format | Online Article Text |
id | pubmed-10653416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-106534162023-11-16 Burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (cCMV) infection in Germany: A retrospective statutory health insurance claims database analysis de Lepper, Marion Stephan, Anna-Janina Wölle, Regine Wang, Wei Jacob, Christian Schneider, Kim Maren Buxmann, Horst Goelz, Rangmar Hamprecht, Klaus Kummer, Peter Modrow, Susanne Greiner, Wolfgang Luzak, Agnes Reuschenbach, Miriam PLoS One Research Article BACKGROUND: Congenital cytomegalovirus (cCMV) infection can have a broad range of manifestations. This study aimed to assess cCMV-associated sequelae and healthcare resource utilization (HCRU) in infants during the first year of life in Germany. METHODS: A retrospective, controlled cohort study using German claims data from the Institute for Applied Health Research Berlin (InGef) database was conducted. cCMV-associated sequelae and HCRU during the first year of life were assessed by matching (1:60) infants with at least one inpatient/outpatient cCMV diagnosis (ICD-10-GM: P35.1) ≤90 days after birth (cCMV(90) cohort) and infants with at least one inpatient cCMV diagnosis plus specific sequelae ≤21 days after birth (cCMV(21-S)) to infants without cCMV or CMV (ICD-10-GM: B25) diagnosis (control group), respectively. Outcomes were analyzed during the first 365 days of life. RESULTS: Between 2014–2018, we identified 54 newborns for cCMV(90) and 24 newborns for cCMV(21-S) cohort. Compared to the 3,240 and 1,440 controls, respectively, more cCMV(90) infants (83.3% vs. 41.9%, p<0.01) presented with at least one sequela during the first year of life, including intrauterine growth retardation (42.6% vs. 5.3%, p<0.01), sensorineural hearing loss (SNHL) to deafness (38.9% vs. 2.2%, p<0.01), and motor development disorders (33.3% vs. 10.9%, p<0.01). Further, 13.0% of cCMV(90) infants (vs. 2.3%, p<0.01) suffered from visual impairment. In cCMV(21-S) cohort, intrauterine growth retardation (79.2% vs. 6.0%, p<0.01), prematurity (54.2% vs. 7.3%, p<0.01), and motor development disorders (50.0% vs. 11.0%, p<0.01) were the most frequent sequelae. Infants in the cCMV(90) and cCMV(21-S) cohort had, on average, 7.3 times and 9.5 times more hospitalizations and 2.0 times and 2.1 times more outpatient physician visits than their respective controls (p<0.01). Hospitalized infants with cCMV stayed, on average, significantly longer in hospital compared to their controls (cCMV(90) cohort: 30.3 days vs. 9.0 days, p<0.01; cCMV(21-S) cohort: 46.5 days vs. 9.3 days, p<0.01). CONCLUSIONS: cCMV-infection shows a considerable disease and healthcare burden during the first year of life. More than 80% of the identified newborns with cCMV suffered from at least one associated sequela during the first year of life, including long-term sequelae such as SNHL (40%) and visual impairment (13%). Additional steps for prevention of cCMV infection and associated sequelae as well as a comprehensive monitoring of disease burden are needed. Public Library of Science 2023-11-16 /pmc/articles/PMC10653416/ /pubmed/37972113 http://dx.doi.org/10.1371/journal.pone.0293869 Text en © 2023 de Lepper et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article de Lepper, Marion Stephan, Anna-Janina Wölle, Regine Wang, Wei Jacob, Christian Schneider, Kim Maren Buxmann, Horst Goelz, Rangmar Hamprecht, Klaus Kummer, Peter Modrow, Susanne Greiner, Wolfgang Luzak, Agnes Reuschenbach, Miriam Burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (cCMV) infection in Germany: A retrospective statutory health insurance claims database analysis |
title | Burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (cCMV) infection in Germany: A retrospective statutory health insurance claims database analysis |
title_full | Burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (cCMV) infection in Germany: A retrospective statutory health insurance claims database analysis |
title_fullStr | Burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (cCMV) infection in Germany: A retrospective statutory health insurance claims database analysis |
title_full_unstemmed | Burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (cCMV) infection in Germany: A retrospective statutory health insurance claims database analysis |
title_short | Burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (cCMV) infection in Germany: A retrospective statutory health insurance claims database analysis |
title_sort | burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (ccmv) infection in germany: a retrospective statutory health insurance claims database analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653416/ https://www.ncbi.nlm.nih.gov/pubmed/37972113 http://dx.doi.org/10.1371/journal.pone.0293869 |
work_keys_str_mv | AT deleppermarion burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT stephanannajanina burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT wolleregine burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT wangwei burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT jacobchristian burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT schneiderkimmaren burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT buxmannhorst burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT goelzrangmar burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT hamprechtklaus burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT kummerpeter burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT modrowsusanne burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT greinerwolfgang burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT luzakagnes burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis AT reuschenbachmiriam burdenofsequelaeandhealthcareresourceutilizationinthefirstyearoflifeininfantsbornwithcongenitalcytomegalovirusccmvinfectioningermanyaretrospectivestatutoryhealthinsuranceclaimsdatabaseanalysis |